News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA) Denies Shareholder Claim That A Chairman Has Been Selected


7/15/2014 7:21:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Teva Pharmaceutical Industries Ltd. (TEVA) denied that it has chosen a new chairman after an activist investor identified Vice Chairman Amir Elstein as the board’s pick to oversee the generic-drug maker.

Moshe Many, Teva’s former vice chairman, informed investor Benny Landa that Elstein was chosen to replace outgoing chairman Phillip Frost, Landa wrote on his blog in a post dated yesterday. He confirmed the contents of the blog in a phone interview today.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg

comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES